Showing results (331-340 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infectionsLei Bao, Morton J Cowan, Kimberly Dunham, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma modelAnette Sundstedt, Mona Celander, Helena Eriksson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: a Southwest Oncology Group studyR P Whitehead, J M Unger, J W Goodwin, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantationR Or, A Ackerstein, A Nagler, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccineB M Sandmaier, D V Oparin, L A Holmberg, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
Plasmacytoid dendritic cells contribute to doxorubicin-induced tumor arrest in a mouse model of pulmonary metastasisMichela Terlizzi, Ada Popolo, Aldo Pinto, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2014
Treatment with a fusion protein of the extracellular domains of NKG2D to IL-15 retards colon cancer growth in miceYan Xia, Bei Chen, Xiaoqing Shao, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2014
Enhancement of DNA vaccine potency against legumainMichal Smahel, Martina Duskova, Ingrid Polakova, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 12, 2014
Cyclophosphamide and IL-12-transduced DCs enhance the antitumor activity of tumor antigen-stimulated DCs and reduce Tregs and MDSCs numberJoanna Rossowska, Elżbieta Pajtasz-Piasecka, Natalia Anger, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2013
Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesotheliomaTetsuzo Tagawa, Licun Wu, Masaki Anraku, et al.Pageof 175